****************IMPORTANT*****************
The MedWatch September 2015 Safety Labeling Changes posting includes 48 products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE.
The “Summary Page” table provides a listing of product names and safety labeling sections revised:
The following drugs had modifications to the
BOXED WARNING, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS:
Accupril (quinapril hydrochloride) Tablets
Accuretic (quinapril hydrochloride/hydrochlorothiazide) Tablets
Altace (ramipril) Capsules
Avastin (bevacizumab)
Brilinta (ticagrelor) Tablets
Bydureon (exenatide extended-release) for Injectable Suspension
Cialis (tadalafil) Tablets
Clozaril (clozapine) Tablets
Combivir (lamivudine and zidovudine) Tablets
Doryx (doxycycline hyclate) Delayed-Release Capsules
Epzicom (abacavir and lamivudine) Tablets
Fazaclo (clozapine) Orally Disintegrating Tablets
Gazyva (obinutuzumab)
Humira (adalimumab) Solution
Invokamet (canagliflozin and metformin HCl) Tablets
Invokana (canagliflozin) Tablets
Levitra (vardenafil hydrochloride) Tablets
Myalept (metreleptin) for Injection
Neulasta (pegfilgrastim) Prefilled Syringe/On-body Injector
Neurontin (gabapentin) Capsules, Tablets, and Syrup
Nicorette (nicotine polacrilex) Gum
Nicorette (nicotine polacrilex) Large Lozenge
PegIntron (peginterferon alfa-2b) Injection, for Subcutaneous Use
Proglycem (diazoxide) Capsules and Oral Suspension
Sabril (vigabatrin) Tablet and Powder for Oral Solution
Sancuso (granisetron)
Staxyn (vardenafil hydrochloride) Orally Disintegrating Tablets
Stendra (avanafil) Tablets
Triumeq (abacavir sulfate, dolutegravir, and lamivudine) Tablets
Trizivir (abacavir, lamivudine, and zidovudine) Tablets
Velcade (bortezomib) for Injection
Versacloz (clozapine) Oral Suspension
Viagra (sildenafil citrate) Tablets
Votrient (pazopanib) Tablets
Xalkori (crizotinib)
Zestril (lisinopril) Tablets
Ziagen (abacavir) Tablets and Oral Solution
From now on I will keep all medicine box label updates posted here as well as on my public profile Facebook page for your guidance!
Because some medicines were not listed in the above update for some reason, I decided to paste here the entire list as it appears on the FDA site. Links are included with each medicine; please click and follow!
September 2015
September 2015
Drug Safety Labeling Changes
The summary view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. The “quick view” table below provides the drug name and sections modified. Click on the drug name to go to the detailed view. The detailed view includes sections and subsections modified, a description of new or modified safety information in the BOXED WARNING, CONTRAINDICATIONS, or WARNINGS sections, and a link to the revised prescribing information.
Key to Label Section Acronyms:
BW=BOXED WARNING, C=CONTRAINDICATIONS, W=WARNINGS, P=PRECAUTIONS AR=ADVERSE REACTIONS, PPI/MG=PATIENT PACKAGE INSERT/MEDICATION GUIDE
Questions are always appreciated! Please share so others can benefit from this update!
Angela
Pingback: Triptans ± SSRIs ± Migraines ± Depression: Flip a Coin!- Hormones Matter
Pingback: Triptans ± SSRIs ± Migraines ± Depression: Flip a Coin! - Hormones Matter
You left out Flouroquinolones
Cipro
Levequin
Avelox
LikeLiked by 1 person
Dear Deniese,
There are no updates to Cipro, Levaquin, or Avelox at the FDA. The latest thing they have up there is the citizen petition I have written about and gave instructions how to add comments (there are 16 comments plus an open comment from a floxed pharmacist as of now) but as you can see in the letter I was sent by the FDA, there are no changes in the status of these drugs. There is a class action lawsuit but that is not an FDA update. This blog post is just an FDA update as I receive them every day via email.
Hope this helps,
Angela
LikeLike